Skip to content

Effect of Granulocyte colony stimulating factor (G-CSF) on in-vitro fertilization (IVF) results

Effect of subcutaneous Granulocyte colony stimulating factor (G-CSF) versus placebo on in-vitro fertilization (IVF) results in patients with recurrent implantation failure (RIF): A double-blind, randomized, controlled, clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230718058835N1
Enrollment
134
Registered
2023-08-12
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility. Female infertility of uterine origin

Interventions

Intervention 1: Intervention group: Intervention group: Granulocyte Colony Stimulating Factor (G-CSF), 300µg, single dose, subcutaneous, injected one hour before embryo transfer. Intervention 2: Contr

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age less than 40 years maximum FSH level of 15 IU/ml repeated IVF failure absence of contraindications to receiving G-CSF (active infection, tuberculosis cycle disease, chronic neutropenia, history of malignancy in the past, current malignancy, renal failure, upper respiratory tract infection, congenital fructose intolerance) absence of any systemic diseases (hypertension, diabetes, antiphospholipid syndrome, lupus, thrombophilia and thyroid diseases)

Exclusion criteria

Exclusion criteria: Insufficient endometrial thickness (minimum 7 mm on the day of HCG injection) hypersensitivity to GCSF diagnosis of Asherman's syndrome diagnosis of polyps and fibroids by hysteroscopy refusal to participate in the study

Design outcomes

Secondary

MeasureTime frame
Clinical pregnancy rate. Timepoint: 4-6 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.

Primary

MeasureTime frame
Chemical pregnancy rate. Timepoint: two weeks after embryo transfer. Method of measurement: serum level of ß-HCG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Ehsan Mousavi

Tabriz University of Medical Sciences

drehsanmousavii@gmail.com+98 41 3332 1925

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026